1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

Cell lines tested with erlotinib:PLX-4032 (2:1 mol/mol)

777 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with erlotinib:PLX-4032 (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2136
lungCTRPv2124
N/ACTRPv248
skinCTRPv244
large intestineCTRPv243
central nervous systemCTRPv243
pancreasCTRPv240
ovaryCTRPv239
breastCTRPv235
stomachCTRPv230
Download CSV
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAM9A CTRPv2 AAC 0.25 7e-12
mRNA XDH CTRPv2 AAC 0.26 8e-11
mRNA IRF6 CTRPv2 AAC 0.31 1e-10
mRNA TEX13B CTRPv2 AAC 0.23 3e-10
mRNA S100A9 CTRPv2 AAC 0.22 4e-09
mRNA GPR87 CTRPv2 AAC 0.28 1e-08
mRNA C1orf74 CTRPv2 AAC 0.21 2e-08
mRNA CSTA CTRPv2 AAC 0.23 2e-08
mRNA LPCAT2 CTRPv2 AAC 0.22 4e-08
mRNA AC006386.1 CTRPv2 AAC 0.2 4e-08
Download CSV